GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Anadys Pharmaceuticals, Inc. (ANDS) [hlAlert]

Rating:
Positive ANDS
up 42.85 %

Anadys Pharmaceuticals, Inc. (ANDS) rated Positive with price target $5 by Susquehanna Financial

Posted on: Friday,  May 30, 2008  8:25 AM ET by Susquehanna Financial

Susquehanna Financial rated Positive Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 05/30/2008, when the stock price was $2.59. Since
then, Anadys Pharmaceuticals, Inc. has gained 42.86% as of 11/23/2011's recent price of $3.70.
If you would have followed this Susquehanna Financial's recommendation on ANDS, you would have gained 42.85% of your investment in 1272 days.

Anadys Pharmaceuticals, Inc., is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule medicines for the treatment of viral diseases and cancer. The Company's programs focus on Toll-Like Receptor-based small molecule product candidates and direct antiviral compounds that inhibit key steps in viral proliferation. The Company has core expertise in medicinal chemistry coupled with structure-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

Since its inception in 1987, the Susquehanna International Group of Companies (SIG)* has grown from a trading firm on the Philadelphia Stock Exchange to one of the largest privately held financial institutions in the world. With more than 1,500 employees worldwide, SIG sits at the helm of the latest trends and developments in trading and market making, institutional sales, research, private equity, venture capital, and investment banking. SIG has offices across North America, Europe, Asia, and Australia. SIG distinguishes itself through its global market presence, capital commitment, and its grasp of trading dynamics. It excels at decision theory and implementing sophisticated pricing probability models.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/30/2008 8:25 AM Buy
None
2.59 5.00
as of 12/24/2008
1 Week down  -51.65 %
1 Month down  -52.89 %
3 Months down  -37.52 %
1 YTD up  86.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy